Nifty
Sensex
:
:
14581.45
48803.68
76.65 (0.53%)
259.62 (0.53%)

Pharmaceuticals & Drugs - Veterinary

Rating :
57/99

BSE: 524669 | NSE: HESTERBIO

2013.95
15-Apr-2021
  • Open
  • High
  • Low
  • Previous Close
  •  2024.00
  •  2041.95
  •  1980.65
  •  2016.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4212
  •  84.95
  •  2280.00
  •  971.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,712.43
  • 62.51
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,809.58
  • 0.33%
  • 7.76

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.73%
  • 3.92%
  • 31.35%
  • FII
  • DII
  • Others
  • 0.6%
  • 0.82%
  • 9.58%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.88
  • 12.68
  • 10.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.98
  • 10.84
  • 3.40

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.46
  • 8.74
  • 4.42

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.54
  • 37.42
  • 38.50

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.89
  • 7.30
  • 7.23

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.79
  • 22.28
  • 21.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
56.89
50.69
12.23%
53.41
44.20
20.84%
39.85
44.76
-10.97%
43.62
49.75
-12.32%
Expenses
35.72
29.99
19.11%
37.61
33.14
13.49%
27.95
27.19
2.80%
36.43
32.04
13.70%
EBITDA
21.18
20.70
2.32%
15.80
11.05
42.99%
11.90
17.57
-32.27%
7.19
17.71
-59.40%
EBIDTM
37.22%
40.83%
29.59%
25.01%
29.86%
39.26%
16.48%
35.60%
Other Income
1.27
0.30
323.33%
0.24
0.70
-65.71%
0.69
0.57
21.05%
4.79
5.75
-16.70%
Interest
1.52
2.63
-42.21%
2.11
1.41
49.65%
1.53
1.90
-19.47%
2.54
2.10
20.95%
Depreciation
3.27
3.42
-4.39%
3.24
3.23
0.31%
3.18
3.23
-1.55%
3.20
3.64
-12.09%
PBT
17.66
14.95
18.13%
10.69
7.11
50.35%
7.88
13.02
-39.48%
6.24
17.71
-64.77%
Tax
4.79
3.00
59.67%
4.01
0.91
340.66%
2.83
4.94
-42.71%
1.48
3.64
-59.34%
PAT
12.87
11.95
7.70%
6.68
6.21
7.57%
5.05
8.09
-37.58%
4.76
14.07
-66.17%
PATM
22.62%
23.57%
12.51%
14.04%
12.67%
18.07%
10.91%
28.29%
EPS
14.51
13.54
7.16%
7.85
7.67
2.35%
6.72
9.86
-31.85%
3.22
15.47
-79.19%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
193.77
183.27
178.07
135.94
123.11
100.89
90.64
69.05
65.10
48.26
41.97
Net Sales Growth
2.31%
2.92%
30.99%
10.42%
22.02%
11.31%
31.27%
6.07%
34.89%
14.99%
 
Cost Of Goods Sold
35.41
19.71
28.47
23.31
28.45
19.75
25.32
11.39
15.42
7.75
6.37
Gross Profit
158.36
163.56
149.60
112.63
94.65
81.14
65.32
57.65
49.68
40.51
35.60
GP Margin
81.72%
89.25%
84.01%
82.85%
76.88%
80.42%
72.07%
83.49%
76.31%
83.94%
84.82%
Total Expenditure
137.71
127.41
110.03
88.68
82.09
67.50
65.90
44.60
43.21
29.66
23.95
Power & Fuel Cost
-
8.13
7.83
6.37
5.59
5.81
4.77
4.40
3.30
2.96
2.32
% Of Sales
-
4.44%
4.40%
4.69%
4.54%
5.76%
5.26%
6.37%
5.07%
6.13%
5.53%
Employee Cost
-
40.65
28.93
23.24
18.32
15.44
12.32
9.84
9.06
6.87
5.82
% Of Sales
-
22.18%
16.25%
17.10%
14.88%
15.30%
13.59%
14.25%
13.92%
14.24%
13.87%
Manufacturing Exp.
-
13.21
11.34
9.45
7.06
7.85
5.25
5.28
4.15
4.09
2.88
% Of Sales
-
7.21%
6.37%
6.95%
5.73%
7.78%
5.79%
7.65%
6.37%
8.47%
6.86%
General & Admin Exp.
-
21.63
13.72
13.81
11.47
10.23
8.90
7.23
6.09
4.76
3.93
% Of Sales
-
11.80%
7.70%
10.16%
9.32%
10.14%
9.82%
10.47%
9.35%
9.86%
9.36%
Selling & Distn. Exp.
-
18.99
16.77
9.11
8.15
6.77
7.14
4.87
4.34
2.68
2.34
% Of Sales
-
10.36%
9.42%
6.70%
6.62%
6.71%
7.88%
7.05%
6.67%
5.55%
5.58%
Miscellaneous Exp.
-
5.10
2.98
3.40
3.05
1.64
2.20
1.58
0.84
0.54
2.34
% Of Sales
-
2.78%
1.67%
2.50%
2.48%
1.63%
2.43%
2.29%
1.29%
1.12%
0.64%
EBITDA
56.07
55.86
68.04
47.26
41.02
33.39
24.74
24.45
21.89
18.60
18.02
EBITDA Margin
28.94%
30.48%
38.21%
34.77%
33.32%
33.10%
27.29%
35.41%
33.63%
38.54%
42.94%
Other Income
6.99
6.37
7.21
2.55
0.42
0.88
0.34
0.79
0.20
0.24
0.13
Interest
7.70
7.67
6.63
4.04
3.50
3.72
4.83
6.46
3.26
2.83
2.53
Depreciation
12.89
13.23
11.76
9.66
7.00
5.75
5.92
5.41
4.43
4.12
4.48
PBT
42.47
41.33
56.86
36.12
30.93
24.81
14.33
13.37
14.41
11.90
11.15
Tax
13.11
10.32
16.16
13.05
8.15
5.63
4.82
4.20
5.34
4.41
3.59
Tax Rate
30.87%
24.97%
28.42%
36.13%
26.35%
22.69%
28.39%
31.41%
37.06%
37.06%
32.20%
PAT
29.36
29.17
41.56
25.62
23.55
19.19
12.47
9.45
9.26
7.61
7.56
PAT before Minority Interest
27.49
31.00
40.69
23.07
22.79
19.18
12.17
9.16
9.07
7.49
7.56
Minority Interest
-1.87
-1.83
0.87
2.55
0.76
0.01
0.30
0.29
0.19
0.12
0.00
PAT Margin
15.15%
15.92%
23.34%
18.85%
19.13%
19.02%
13.76%
13.69%
14.22%
15.77%
18.01%
PAT Growth
-27.18%
-29.81%
62.22%
8.79%
22.72%
53.89%
31.96%
2.05%
21.68%
0.66%
 
EPS
34.54
34.32
48.89
30.14
27.71
22.58
14.67
11.12
10.89
8.95
8.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
201.07
177.46
140.63
121.95
101.71
84.92
75.01
67.30
59.76
47.90
Share Capital
8.51
8.51
8.51
8.51
8.51
8.51
8.51
8.51
5.67
5.19
Total Reserves
192.57
168.95
132.13
113.44
93.20
76.41
66.50
58.79
54.09
41.07
Non-Current Liabilities
96.64
69.64
44.41
48.32
41.28
37.66
20.46
16.31
6.15
6.06
Secured Loans
76.48
58.35
36.54
44.62
33.09
30.89
14.76
13.71
1.29
3.51
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.90
0.76
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
81.34
48.66
54.63
38.01
38.20
35.01
45.47
38.89
28.22
27.70
Trade Payables
18.61
8.75
7.90
7.47
5.84
4.63
4.52
5.71
4.06
3.34
Other Current Liabilities
30.17
17.15
20.26
11.04
9.30
6.35
7.41
8.84
4.21
4.71
Short Term Borrowings
32.54
22.50
25.41
18.32
21.04
20.08
29.74
16.08
12.73
14.79
Short Term Provisions
0.02
0.26
1.07
1.18
2.02
3.95
3.80
8.27
7.21
4.87
Total Liabilities
384.47
299.46
244.04
212.88
185.84
160.46
142.22
123.70
95.43
82.30
Net Block
142.54
144.82
110.22
102.62
64.63
59.60
53.82
37.73
39.39
39.17
Gross Block
226.32
215.94
170.22
152.95
108.25
97.57
86.69
65.25
62.49
58.14
Accumulated Depreciation
83.78
70.98
60.00
50.33
43.62
37.97
32.87
27.52
23.09
18.97
Non Current Assets
226.86
157.80
145.59
132.91
111.63
100.45
85.12
73.90
49.30
44.11
Capital Work in Progress
74.15
7.05
31.81
21.29
36.46
32.60
20.55
28.89
6.30
0.04
Non Current Investment
0.00
0.00
0.00
0.00
0.07
0.28
0.28
0.28
0.00
0.00
Long Term Loans & Adv.
6.30
4.34
3.48
8.52
10.47
7.97
10.47
7.00
3.60
4.89
Other Non Current Assets
3.87
1.58
0.08
0.47
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
157.62
141.66
98.45
79.97
74.20
60.00
57.10
49.80
46.12
38.19
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
63.97
50.79
39.76
33.41
33.62
29.11
35.59
31.10
27.56
22.68
Sundry Debtors
58.44
32.87
32.29
26.53
26.24
17.76
14.06
15.04
14.36
13.22
Cash & Bank
23.53
41.05
13.39
11.48
5.28
6.58
4.85
2.63
3.70
1.59
Other Current Assets
11.68
5.63
4.06
3.48
9.05
6.55
2.60
1.03
0.50
0.70
Short Term Loans & Adv.
8.62
11.32
8.95
5.06
2.49
6.55
2.60
1.03
0.50
0.70
Net Current Assets
76.28
92.99
43.82
41.95
36.00
25.00
11.63
10.91
17.90
10.49
Total Assets
384.48
299.46
244.04
212.88
185.83
160.45
142.22
123.70
95.42
82.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
38.29
46.71
38.02
34.80
18.85
19.76
9.39
11.54
14.16
5.15
PBT
41.33
56.86
36.12
30.93
24.81
18.20
13.37
14.41
11.90
11.15
Adjustment
19.71
17.92
13.63
10.86
9.38
7.34
11.91
7.67
6.75
6.86
Changes in Working Capital
-13.65
-12.26
-2.31
0.11
-9.37
-0.33
-6.02
-5.04
-3.76
-10.37
Cash after chg. in Working capital
47.39
62.52
47.44
41.90
24.82
25.21
19.25
17.04
14.89
7.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-10.94
-15.81
-9.41
-7.06
-5.97
-5.45
-9.86
-5.50
-0.73
-2.49
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
1.84
0.00
0.00
-0.04
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-74.47
-21.73
-25.83
-30.19
-13.30
-21.21
-14.59
-22.55
-10.23
-3.71
Net Fixed Assets
-5.37
-11.03
-20.52
-15.30
-6.87
-12.04
-10.39
-20.32
-7.74
Net Investments
-12.45
-13.74
-5.88
0.07
0.21
-5.25
-0.85
-0.28
0.00
Others
-56.65
3.04
0.57
-14.96
-6.64
-3.92
-3.35
-1.95
-2.49
Cash from Financing Activity
18.62
2.65
-11.08
1.83
-6.68
6.76
7.38
9.90
-1.84
-0.81
Net Cash Inflow / Outflow
-17.56
27.63
1.12
6.45
-1.14
5.31
2.19
-1.12
2.10
0.64
Opening Cash & Equivalents
40.65
12.33
11.18
4.73
6.12
0.82
2.29
3.41
1.32
0.96
Closing Cash & Equivalent
23.09
40.65
12.33
11.18
4.99
6.12
4.48
2.29
3.41
1.59

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
236.36
208.61
165.32
143.35
119.56
96.86
88.18
79.11
70.25
59.41
ROA
9.07%
14.97%
10.10%
11.43%
11.08%
8.06%
6.89%
8.28%
8.42%
9.19%
ROE
16.38%
25.59%
17.57%
20.38%
20.56%
15.46%
12.88%
14.28%
14.12%
16.35%
ROCE
16.63%
26.64%
20.20%
19.75%
18.98%
16.53%
17.78%
20.10%
20.27%
19.76%
Fixed Asset Turnover
0.83
0.92
0.84
0.96
1.00
1.01
0.93
1.04
0.81
0.72
Receivable days
90.92
66.77
78.70
76.80
77.96
63.83
75.19
80.59
103.02
114.79
Inventory Days
114.27
92.80
97.89
97.55
111.14
127.14
172.29
160.79
187.67
196.97
Payable days
42.44
27.25
33.70
33.48
29.56
28.17
45.39
41.89
45.17
53.81
Cash Conversion Cycle
162.75
132.33
142.89
140.87
159.54
162.80
202.09
199.49
245.52
257.95
Total Debt/Equity
0.60
0.51
0.49
0.54
0.58
0.71
0.64
0.48
0.27
0.46
Interest Cover
6.39
9.57
9.95
9.84
7.67
4.52
3.07
5.41
5.21
5.41

News Update:


  • Hester acquires technology for production, commercialization of classical swine fever vaccine, sheep pox vaccine
    8th Apr 2021, 13:19 PM

    These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.